PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 85 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $149,000 | +2.8% | 58,100 | 0.0% | 0.00% | – |
| Q4 2020 | $145,000 | +20.8% | 58,100 | 0.0% | 0.00% | – |
| Q3 2020 | $120,000 | -37.2% | 58,100 | -5.8% | 0.00% | – |
| Q2 2020 | $191,000 | +70.5% | 61,700 | +25.9% | 0.00% | – |
| Q1 2020 | $112,000 | -26.8% | 49,000 | +15.8% | 0.00% | – |
| Q4 2019 | $153,000 | +6.2% | 42,300 | 0.0% | 0.00% | – |
| Q3 2019 | $144,000 | -86.8% | 42,300 | -81.8% | 0.00% | -100.0% |
| Q2 2019 | $1,092,000 | +45.4% | 232,390 | +3.7% | 0.00% | – |
| Q1 2019 | $751,000 | +21.7% | 224,190 | -3.3% | 0.00% | – |
| Q4 2018 | $617,000 | -24.2% | 231,790 | +59.4% | 0.00% | -100.0% |
| Q3 2018 | $814,000 | +13.5% | 145,380 | +2.8% | 0.00% | – |
| Q2 2018 | $717,000 | -1.0% | 141,480 | +33.4% | 0.00% | -100.0% |
| Q1 2018 | $724,000 | +470.1% | 106,090 | +531.5% | 0.00% | – |
| Q4 2017 | $127,000 | +69.3% | 16,800 | +29.2% | 0.00% | – |
| Q3 2017 | $75,000 | +13.6% | 13,000 | 0.0% | 0.00% | – |
| Q2 2017 | $66,000 | – | 13,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 1,136,319 | $3,443,000 | 3.20% |
| Aquilo Capital Management, LLC | 3,708,882 | $11,238,000 | 1.65% |
| Soleus Capital Management, L.P. | 4,134,868 | $12,529,000 | 1.62% |
| GREAT POINT PARTNERS LLC | 2,199,076 | $6,663,000 | 1.61% |
| BVF INC/IL | 5,328,239 | $16,145,000 | 0.65% |
| Cutter & CO Brokerage, Inc. | 406,229 | $1,231,000 | 0.37% |
| WEALTH EFFECTS LLC | 80,400 | $244,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,028,322 | $3,116,000 | 0.10% |
| Rhenman & Partners Asset Management AB | 300,000 | $909,000 | 0.09% |
| Woodline Partners LP | 1,587,475 | $4,810,000 | 0.08% |